Cerence Inc.
8.34USD
-0.3100 (-3.58%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CRNC.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.22▲ | $0.2 | 2 | 0 |
| Next quarter | $0.15▼ | $0.2 | 0 | 1 |
| Current year | $0.73▲ | $0.71 | 2 | 0 |
| Next year | $0.79▲ | $0.77 | 1 | 1 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.2 | $0.21 | +0.02 (+9.2%) |
| 2026-03-31 | $0.14 | $0.18 | +0.05 (+34.1%) |
| 2025-12-31 | $0.31 | $0.18 | -0.13 (-43.3%) |
| 2025-09-30 | -$0.26 | -$0.12 | +0.14 (+52.7%) |
119 ratings from 14 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Goldman Sachs | Maintained | Neutral | $8 $9 | May 8, 2026 |
| Cantor Fitzgerald | Initiated | Overweight | $11 | Apr 2, 2026 |
| Goldman Sachs | Maintained | Neutral | $11 $8 | Feb 9, 2026 |
| TD Cowen | Maintained | Hold | $13 $12 | Feb 5, 2026 |
| Goldman Sachs | Maintained | Neutral | $10 $11 | Nov 20, 2025 |
| Goldman Sachs | Maintained | Neutral | $9 $10 | Aug 7, 2025 |
| Goldman Sachs | Maintained | Neutral | $8 $9 | May 9, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $12 $10 | May 8, 2025 |
| Goldman Sachs | Maintained | Neutral | $14 $8 | Apr 10, 2025 |
| Needham | Reiterated | Buy | $16 | Mar 18, 2025 |
| Evercore ISI Group | Maintained | In-Line | $6 $9 | Feb 18, 2025 |
| Needham | Reiterated | Buy | $16 | Feb 7, 2025 |
| Needham | Upgraded from Hold | Buy | $16 | Jan 22, 2025 |
| Goldman Sachs | Maintained | Neutral | $8 $14 | Jan 16, 2025 |
| Needham | Reiterated | Hold | — | Nov 25, 2024 |
| Craig-Hallum | Maintained | Hold | $3.5 $6 | Nov 22, 2024 |
| TD Cowen | Maintained | Buy | $12 $10 | Aug 9, 2024 |
| Wells Fargo | Maintained | Equal-Weight | $6.5 $3.3 | Aug 9, 2024 |
| Needham | Reiterated | Hold | — | Aug 9, 2024 |
| Evercore ISI Group | Maintained | In-Line | $8 $5 | Jul 15, 2024 |
| Baird | Maintained | Neutral | $8 $6 | Jul 12, 2024 |
| Goldman Sachs | Maintained | Neutral | $6 $3 | Jul 10, 2024 |
| Goldman Sachs | Maintained | Neutral | $19 $6 | May 13, 2024 |
| Craig-Hallum | Maintained | Hold | $22 $8 | May 10, 2024 |
| Wedbush | Maintained | Neutral | $21 $9 | May 10, 2024 |
43 filings from 14 insiders · 0 buy / 0 sell over 6m
Officers and directors of CRNC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| KRZANICH BRIAN MChief Executive Officer | Sell | 131.7k | $8.26 | $1.09M | Oct 9, 2026 |
| SALINAS JENNIFEROfficer | Sell | 26.0k | $8.83 | $230k | Aug 10, 2026 |
| KLEVORN MARCY SDirector | Grant | 13.0k | $7.94 | $103k | Feb 12, 2026 |
| BUDNIK MARIANNEDirector | Grant | 13.0k | $7.94 | $103k | Feb 12, 2026 |
| MATUS KRISTI ANNDirector | Grant | 13.0k | $7.94 | $103k | Feb 12, 2026 |
| HARRIS MARIONDirector | Grant | 13.0k | $7.94 | $103k | Feb 12, 2026 |
| DAVIS DOUGLAS LEEDirector | Grant | 13.0k | $7.94 | $103k | Feb 12, 2026 |
| KRZANICH BRIAN MChief Executive Officer | Grant | 263.3k | $12.35 | $3.25M | Jan 9, 2026 |
| RODRIQUEZ ANTONIOChief Financial Officer | Grant | 131.7k | $12.35 | $1.63M | Jan 9, 2026 |
| MENTZ CHRISTIANOfficer | Grant | 131.7k | $12.35 | $1.63M | Jan 9, 2026 |
| SCHANZ NILSOfficer | Grant | 87.8k | $12.35 | $1.08M | Jan 9, 2026 |
| SALINAS JENNIFEROfficer | Grant | 131.7k | $12.35 | $1.63M | Jan 9, 2026 |
| KRZANICH BRIAN MChief Executive Officer | Grant | 552.8k | $10.35 | $5.72M | Nov 21, 2025 |
| RODRIQUEZ ANTONIOChief Financial Officer | Grant | 166.8k | $10.35 | $1.73M | Nov 21, 2025 |
| MENTZ CHRISTIANOfficer | Grant | 49.9k | $10.35 | $517k | Nov 21, 2025 |
| SCHANZ NILSOfficer | Grant | 49.9k | $10.35 | $517k | Nov 21, 2025 |
| SALINAS JENNIFEROfficer | Grant | 242.0k | $10.35 | $2.51M | Nov 21, 2025 |
| KRZANICH BRIAN MChief Executive Officer | Sell | 132.1k | $11.46 | $1.51M | Oct 9, 2025 |
| SALINAS JENNIFEROfficer | Sell | 142.8k | $12.31 | $1.79M | Oct 7, 2025 |
| RODRIQUEZ ANTONIOChief Financial Officer | Sell | 38.3k | $12.76 | $489k | Oct 6, 2025 |
Analyst Ratings
4 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 1 | 4 | 0 | 0 | Hold2.80 |
Members whose judged calls on CRNC have played out most reliably.
No settled calls on CRNC yet. 1 call is open, the first due Oct 18, 2027.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice